I'm 59 & I am not on TRT protocol so I don't know that I can say what mistakes I have made I guess I'm an abuser I started with 6 week cycle of Dbol 25mg/day for 6 weeks I was to wimpy to do injections so I did orals which Dbol is suppose to help with oesteoperosis & I have been suffering all my life with rotator cuff issues since birth they pulled me out with forceps dislocating both shoulders & left me that way. So frustration & no help from doctors I turned to working out & supplementation. After Dbol cycle naturally I felt like crap. Doctor refused to do hormone blood work. So I suffered from mid Feb Till mid April When I started injecting 250mg test E 2x/week This made me feel great Then in mid june I added 250mg 1x/week Deca. For the first time in my life pain in shoulders subsided by mid July This was like a miracle for me Doctors were never able to do this through surgery or pain meds. I also was even more stupid as for july & august I added 50mg/day of anavar & 12.5mg aromasin daily. I never gained any weight or muscle or strength as you already know my rotators hold me back from heavy weights I try to eat clean but not really none the less I give my honest best effort in the gym every second day I find this worked best for old guy like me. So now that I seen this blood work I stopped Deca its been 9 days & pain is back with a vengance. I cut aromasin back to only 3x/week. Today I injected 125mg TestE. The Dbol also helped with shoulder problem. I know what I have done is wrong. So give me hell I deserve it. I suspect that my high Ketones could be a false positive as I take 3grams of vitamin C / day & C can cause false positive I'm not saying labs are wrong its just my 2cents. I have always had good blood pressure but no more since june I have been on Mavik 1mg/day & its never come down. Hope this doesn't get me kicked out of here as I just joined to try to learn. This is as honest as I can get. Anything else just ask.Adding 5'8" 165lbs none smoker I'm in Canada & were I live you can't donate blood I would have to travel 11 hours to donate. I'm schedualed to see Urologist on Nov 5th. This all started in Jan this year. I only have walk in clinic Doc that told me he knows nothing about hormone supplementation. Uro I'm hoping can get my prostate checked make sure its not cancer. I have asked Doc for a Phlabotamy but he said I don't need it same as donating except Doc orders it cause its needed. What I need is advice on whether I should stop all anabolic or come down slowly should I be doing a pct with nolvadex & clomid or go cold turkey?
First Blood work
Hematology
WBC 7.8 4.0 - 11.0 x E9/L
RBC 5.41 4.50 - 6.00 x E12/L
Hemoglobin 162 135 - 175 g/L
Hematocrit 0.49 0.400 - 0.500 L/L
MCV 90 80 - 100 fL
MCH 29.9 27.5 - 33.0 pg
MCHC 333 305 - 360 g/L
Platelets 263 150 - 400 x E9/L
RDW 14.4 11.5 - 14.5 %
Differential
Neutrophils 3.5 2.0 - 7.5 x E9/L
Lymphocytes 3.3 1.0 - 3.5 x E9/L
Monocytes 0.7 0.2 - 1.0 x E9/L
Eosinophils 0.3 0.0 - 0.5 x E9/L
Basophils 0.0 0.0 - 0.2 x E9/L
Please note changes to PEDIATRIC CBC reference
ranges as of June 15, 2015.
Urinalysis
Urinalysis Chemical
Collection Date 24-SEP-2015
Collection Time 15:56
Colour YELLOW NONE/YELLOW
Appearance CLEAR CLEAR
Specific Gravity 1.025 1.001 - 1.030
pH 5.0 5.0 - 8.0
Protein NEGATIVE NEGATIVE g/L
Glucose NEGATIVE NEGATIVE mmol/L
Ketones HI 0.5 NEGATIVE mmol/L
Erythrocytes NEGATIVE NEGATIVE mg/L
Nitrite NEGATIVE NEGATIVE
Leukocyte Esterase NEGATIVE NEGATIVE WBC/uL
Please note change in methodology and reporting
for urinalysis: chemical.
General Chemistry
Hemoglobin A1C/Total Hemoglobin 5.1 <6.0 %
Note: Change to reporting units and
interpretation. For more information,
go to
CDA 2013 Guidelines:
-------------------------------------------------
Screening and Diagnosis:
<5.5 % Normal
5.5% - 5.9 % At risk
6.0% - 6.4 % Prediabetes
>OR= 6.5 % Diabetes Mellitus
If HbA1c >OR= 6.5 % and asymptomatic, confirm
using Fasting Glucose, HbA1c or 75g OGTT.
-------------------------------------------------
Monitoring:
Target in adults without comorbidities. Other
targets may be more appropriate in children,
elderly and patients with comorbidities.
-------------------------------------------------
Results may not accurately reflect mean blood
glucose in patients with hemoglobin variants,
disorders associated with abnormal erythrocyte
turnover, severe renal and liver disorders.
Sodium 139 135 - 147 mmol/L
Potassium 4.1 3.5 - 5.5 mmol/L
Creatinine 91 62 - 115 umol/L
Glomerular Filtration Rate (eGFR) 79
An eGFR from 60-89 ml/min/1.73 m2 is consistent
with mildly decreased kidney function. However,
in the absence of other evidence of kidney
disease, eGFR values in this range do not fulfill
the KDIGO criteria for chronic kidney disease.
Interpret results in concert with ACR measurement.
For patients of African descent, the reported
eGFR must be multiplied by 1.15.
Effective May 4 2015, eGFR is calculated using
the CKD-EPI 2009 equation.
KDIGO 2012 guidelines highlight the importance of
eGFR and urine albumin creatinine ratio (ACR) in
screening, diagnosis and management of CKD.
Results for eGFR should be interpreted in concert
with ACR.
Bilirubin Total 7 < 22 umol/L
Alkaline Phosphatase 49 45 - 129 U/L
Alanine Aminotransferase 39 12 - 49 U/L
Lipids
Hours After Meal 3 Hours
Triglyceride 1.50 mmol/L
Cholesterol 4.07 mmol/L
HDL Cholesterol 0.82 mmol/L
Non HDL Cholesterol 3.25 mmol/L
Non HDL-Cholesterol is calculated from Total
Cholesterol and HDL-c and is not affected by
the fasting status of the patient.
LDL Cholesterol 2.57 mmol/L
LDL-C calculation is decreased if fasting
< or = 10 hours. Consider the Non HDL-C value as
an alternate lipid target if monitoring treatment
in intermediate or high risk patients.
Cholesterol/HDL Ratio 5.0
Cholesterol/HDL-C is not included in the 2012 CCS
guideline as a lipid initiation or treatment
target but is recognized as an indicator of high
CVD risk at Cholesterol/HDL-C ratio >6.0
Lipid Target Values Lipid Target Values should be based on patient
10 year CVD risk assessment. 2012 revised
treatment goals include:
High or Intermediate CVD risk
-----------------------------------------------
Primary LDL-C < or = 2.0 mmol/L OR
Tx target > or = 50% decrease in LDL-C
Alternate Non HDL-C < or = 2.6 mmol/L OR
Tx target ApoB < or = 0.8 g/L
-----------------------------------------------
Low CVD risk
-----------------------------------------------
Primary > or = 50% decrease in LDL-C
Tx target
Pituitary Function
Follicle Stimulating Hormone [FSH] LO <^1 2 - 8 IU/L
Luteinizing Hormone [LH] LO <^1 2 - 6 IU/L
Tumour Markers
Prostate Specific Antigen HI 4.9 < 4.0 ug/L
Test repeated and results confirmed.
Total PSA is assayed using Roche Cobas.
Results should not be interpreted in isolation as
absolute evidence of the presence or absence of
malignant disease. All clinical and diagnostic
information must be considered.
Changes in serial levels may be misleading unless
all Total PSA tests are performed by the same
laboratory.
To facilitate clinical diagnosis measurement of
Free PSA is suggested in situations where the
Total PSA concentration is between
4.0 and 10.0 ug/L.
Reproductive and Gonadal
Estradiol 146 < 150 pmol/L
Testosterone HI >^120.0 8.4 - 28.8 nmol/L
Test repeated and results confirmed.
Total Testosterone levels may not reflect the
biologically-active testosterone when SHBG levels
are abnormal.
Testosterone Free Unable to calculate Free Testosterone as Total
Testosterone is >120.0 nmol/L, the upper limit
of quantitation.
Labs were done Sept 24th I have since only used 125mg testE 2 times But have added Dbol 50mg a day as it helps my shoulders in the gym guess I'm tripping here this is wrong isn't it now I have added 25mg a day clomid aromasin 3times a week 12.5mg & pure essence triple stack 2 days now any advice or help would be appreciated Best Regards Phil
First Blood work
Hematology
WBC 7.8 4.0 - 11.0 x E9/L
RBC 5.41 4.50 - 6.00 x E12/L
Hemoglobin 162 135 - 175 g/L
Hematocrit 0.49 0.400 - 0.500 L/L
MCV 90 80 - 100 fL
MCH 29.9 27.5 - 33.0 pg
MCHC 333 305 - 360 g/L
Platelets 263 150 - 400 x E9/L
RDW 14.4 11.5 - 14.5 %
Differential
Neutrophils 3.5 2.0 - 7.5 x E9/L
Lymphocytes 3.3 1.0 - 3.5 x E9/L
Monocytes 0.7 0.2 - 1.0 x E9/L
Eosinophils 0.3 0.0 - 0.5 x E9/L
Basophils 0.0 0.0 - 0.2 x E9/L
Please note changes to PEDIATRIC CBC reference
ranges as of June 15, 2015.
Urinalysis
Urinalysis Chemical
Collection Date 24-SEP-2015
Collection Time 15:56
Colour YELLOW NONE/YELLOW
Appearance CLEAR CLEAR
Specific Gravity 1.025 1.001 - 1.030
pH 5.0 5.0 - 8.0
Protein NEGATIVE NEGATIVE g/L
Glucose NEGATIVE NEGATIVE mmol/L
Ketones HI 0.5 NEGATIVE mmol/L
Erythrocytes NEGATIVE NEGATIVE mg/L
Nitrite NEGATIVE NEGATIVE
Leukocyte Esterase NEGATIVE NEGATIVE WBC/uL
Please note change in methodology and reporting
for urinalysis: chemical.
General Chemistry
Hemoglobin A1C/Total Hemoglobin 5.1 <6.0 %
Note: Change to reporting units and
interpretation. For more information,
go to
CDA 2013 Guidelines:
-------------------------------------------------
Screening and Diagnosis:
<5.5 % Normal
5.5% - 5.9 % At risk
6.0% - 6.4 % Prediabetes
>OR= 6.5 % Diabetes Mellitus
If HbA1c >OR= 6.5 % and asymptomatic, confirm
using Fasting Glucose, HbA1c or 75g OGTT.
-------------------------------------------------
Monitoring:
Target in adults without comorbidities. Other
targets may be more appropriate in children,
elderly and patients with comorbidities.
-------------------------------------------------
Results may not accurately reflect mean blood
glucose in patients with hemoglobin variants,
disorders associated with abnormal erythrocyte
turnover, severe renal and liver disorders.
Sodium 139 135 - 147 mmol/L
Potassium 4.1 3.5 - 5.5 mmol/L
Creatinine 91 62 - 115 umol/L
Glomerular Filtration Rate (eGFR) 79
An eGFR from 60-89 ml/min/1.73 m2 is consistent
with mildly decreased kidney function. However,
in the absence of other evidence of kidney
disease, eGFR values in this range do not fulfill
the KDIGO criteria for chronic kidney disease.
Interpret results in concert with ACR measurement.
For patients of African descent, the reported
eGFR must be multiplied by 1.15.
Effective May 4 2015, eGFR is calculated using
the CKD-EPI 2009 equation.
KDIGO 2012 guidelines highlight the importance of
eGFR and urine albumin creatinine ratio (ACR) in
screening, diagnosis and management of CKD.
Results for eGFR should be interpreted in concert
with ACR.
Bilirubin Total 7 < 22 umol/L
Alkaline Phosphatase 49 45 - 129 U/L
Alanine Aminotransferase 39 12 - 49 U/L
Lipids
Hours After Meal 3 Hours
Triglyceride 1.50 mmol/L
Cholesterol 4.07 mmol/L
HDL Cholesterol 0.82 mmol/L
Non HDL Cholesterol 3.25 mmol/L
Non HDL-Cholesterol is calculated from Total
Cholesterol and HDL-c and is not affected by
the fasting status of the patient.
LDL Cholesterol 2.57 mmol/L
LDL-C calculation is decreased if fasting
< or = 10 hours. Consider the Non HDL-C value as
an alternate lipid target if monitoring treatment
in intermediate or high risk patients.
Cholesterol/HDL Ratio 5.0
Cholesterol/HDL-C is not included in the 2012 CCS
guideline as a lipid initiation or treatment
target but is recognized as an indicator of high
CVD risk at Cholesterol/HDL-C ratio >6.0
Lipid Target Values Lipid Target Values should be based on patient
10 year CVD risk assessment. 2012 revised
treatment goals include:
High or Intermediate CVD risk
-----------------------------------------------
Primary LDL-C < or = 2.0 mmol/L OR
Tx target > or = 50% decrease in LDL-C
Alternate Non HDL-C < or = 2.6 mmol/L OR
Tx target ApoB < or = 0.8 g/L
-----------------------------------------------
Low CVD risk
-----------------------------------------------
Primary > or = 50% decrease in LDL-C
Tx target
Pituitary Function
Follicle Stimulating Hormone [FSH] LO <^1 2 - 8 IU/L
Luteinizing Hormone [LH] LO <^1 2 - 6 IU/L
Tumour Markers
Prostate Specific Antigen HI 4.9 < 4.0 ug/L
Test repeated and results confirmed.
Total PSA is assayed using Roche Cobas.
Results should not be interpreted in isolation as
absolute evidence of the presence or absence of
malignant disease. All clinical and diagnostic
information must be considered.
Changes in serial levels may be misleading unless
all Total PSA tests are performed by the same
laboratory.
To facilitate clinical diagnosis measurement of
Free PSA is suggested in situations where the
Total PSA concentration is between
4.0 and 10.0 ug/L.
Reproductive and Gonadal
Estradiol 146 < 150 pmol/L
Testosterone HI >^120.0 8.4 - 28.8 nmol/L
Test repeated and results confirmed.
Total Testosterone levels may not reflect the
biologically-active testosterone when SHBG levels
are abnormal.
Testosterone Free Unable to calculate Free Testosterone as Total
Testosterone is >120.0 nmol/L, the upper limit
of quantitation.
Labs were done Sept 24th I have since only used 125mg testE 2 times But have added Dbol 50mg a day as it helps my shoulders in the gym guess I'm tripping here this is wrong isn't it now I have added 25mg a day clomid aromasin 3times a week 12.5mg & pure essence triple stack 2 days now any advice or help would be appreciated Best Regards Phil
